Investors

Company Overview

Positron Corporation is a leading innovator in nuclear medicine, dedicated to advancing molecular imaging and diagnostics through state-of-the-art technology. Our signature products, Attrius PET and NeuSight PET-CT 64- Slice scanner, deliver superior imaging precision and clinical efficiency, empowering healthcare providers with unparalleled diagnostic accuracy for cardiac and oncologic applications.

With more than four decades of experience, Positron is committed to revolutionizing the industry by providing comprehensive solutions that combine imaging technology, clinical support, and customized financial models. Our unique rental and lease-to-own programs make advanced diagnostic tools accessible to practices of all sizes, driving improved patient care and operational success.

Positron is at the forefront of innovation, building strong partnerships with global healthcare providers and investing in next-generation solutions, including our efforts to achieve CE marking and expand into the European and Canadian markets. At Positron, we are not just advancing medical imaging; we are redefining the future of nuclear imaging and patient-centric care.